Literature DB >> 31673954

Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly.

Yanghua Fan1, Yansheng Li2, Yichao Li2, Shanshan Feng1, Xinjie Bao1, Ming Feng3, Renzhi Wang4.   

Abstract

PURPOSE: Preoperative prediction of transsphenoidal surgical (TSS) response is important for determining individual treatment strategies for acromegaly. There is currently no accurate predictive model for TSS response for acromegaly. The current study sought to develop and validate machine learning (ML)-based models for preoperative prediction of TSS response for acromegaly.
METHODS: Six hundred sixty-eight patients with acromegaly were enrolled and divided into training (n = 534) and text datasets (n = 134) in this retrospective, data mining and ML study. The forward search algorithm was used to select features, and six ML algorithms were applied to construct TSS response prediction models. The performance of these ML models was validated using receiver operating characteristics analysis. Model calibration, discrimination ability, and clinical usefulness were also assessed.
RESULTS: Three hundred forty-nine (52.2%) patients achieved postoperative remission criteria and exhibited good TSS response. A univariate analysis was conducted and eight features, including age, hypertension, ophthalmic disorders, GH, IGF-1, nadir GH, maximal tumor diameter, and Knosp grade, were significantly associated with the TSS response in patients with acromegaly. After feature selection, the gradient boosting decision tree (GBDT), which was constructed with the eight significant features showed the best favorable discriminatory ability both the training (AUC = 0.8555) and validation (AUC = 0.8178) cohorts. The GBDT model showed good discrimination ability and calibration, with the highest levels of accuracy and specificity, and provided better estimates of TTS responses of patients with acromegaly compared with using only the Knosp grade. Decision curve analysis confirmed that the model was clinically useful.
CONCLUSIONS: ML-based models could aid neurosurgeons in the preoperative prediction of TTS response for patients with acromegaly, and could contribute to determining individual treatment strategies.

Entities:  

Keywords:  Acromegaly; Machine learning; Transsphenoidal surgical; Treatment response

Mesh:

Year:  2019        PMID: 31673954     DOI: 10.1007/s12020-019-02121-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  44 in total

1.  Receiver operating characteristic analysis.

Authors:  Sukru Mehmet Erturk
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

2.  Neural network-based identification of patients at high risk for intraoperative cerebrospinal fluid leaks in endoscopic pituitary surgery.

Authors:  Victor E Staartjes; Costanza M Zattra; Kevin Akeret; Nicolai Maldaner; Giovanni Muscas; Christiaan Hendrik Bas van Niftrik; Jorn Fierstra; Luca Regli; Carlo Serra
Journal:  J Neurosurg       Date:  2019-06-21       Impact factor: 5.115

3.  Predictors of surgical outcome and early criteria of remission in acromegaly.

Authors:  Ximene Antunes; Nina Ventura; Gustavo Bittencourt Camilo; Luiz Eduardo Wildemberg; Andre Guasti; Paulo José M Pereira; Aline Helen Silva Camacho; Leila Chimelli; Paulo Niemeyer; Mônica R Gadelha; Leandro Kasuki
Journal:  Endocrine       Date:  2018-04-06       Impact factor: 3.633

Review 4.  Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system.

Authors:  V S Nunes; J M S Correa; M E S Puga; E M K Silva; C L Boguszewski
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

5.  Predicting Invasive Disease-Free Survival for Early-stage Breast Cancer Patients Using Follow-up Clinical Data.

Authors:  Bo Fu; Pei Liu; Jie Lin; Ling Deng; Kejia Hu; Hong Zheng
Journal:  IEEE Trans Biomed Eng       Date:  2018-11-22       Impact factor: 4.538

6.  Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients.

Authors:  I Shimon; Z R Cohen; Z Ram; M Hadani
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

7.  Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases.

Authors:  Bing Zhao; Yu-Kui Wei; Gui-Lin Li; Yong-Ning Li; Yong Yao; Jun Kang; Wen-Bin Ma; Yi Yang; Ren-Zhi Wang
Journal:  J Neurosurg       Date:  2010-01       Impact factor: 5.115

Review 8.  Molecular markers for bladder cancer: the road to a multimarker approach.

Authors:  Marc Birkhahn; Anirban P Mitra; Richard J Cote
Journal:  Expert Rev Anticancer Ther       Date:  2007-12       Impact factor: 4.512

9.  Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited.

Authors:  Andrew A Kramer; Jack E Zimmerman
Journal:  Crit Care Med       Date:  2007-09       Impact factor: 7.598

10.  Postoperative Gamma Knife Radiosurgery for Cavernous Sinus-Invading Growth Hormone-Secreting Pituitary Adenomas.

Authors:  Eui Hyun Kim; Min Chul Oh; Jong Hee Chang; Ju Hyung Moon; Cheol Ryong Ku; Won-Seok Chang; Eun Jig Lee; Sun Ho Kim
Journal:  World Neurosurg       Date:  2017-11-16       Impact factor: 2.104

View more
  12 in total

1.  Development and assessment of machine learning models for predicting recurrence risk after endovascular treatment in patients with intracranial aneurysms.

Authors:  ShiTeng Lin; Yang Zou; Jue Hu; Lan Xiang; LeHeng Guo; XinPing Lin; DaiZun Zou; Xiaoping Gao; Hui Liang; JianJun Zou; ZhiHong Zhao; XiaoMing Dai
Journal:  Neurosurg Rev       Date:  2021-10-18       Impact factor: 2.800

2.  Machine Learning in Preoperative Prediction of Postoperative Immediate Remission of Histology-Positive Cushing's Disease.

Authors:  Wentai Zhang; Mengke Sun; Yanghua Fan; He Wang; Ming Feng; Shaohua Zhou; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-02       Impact factor: 5.555

Review 3.  The Application of Artificial Intelligence and Machine Learning in Pituitary Adenomas.

Authors:  Congxin Dai; Bowen Sun; Renzhi Wang; Jun Kang
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

Review 4.  Applications of Machine Learning in Bone and Mineral Research.

Authors:  Sung Hye Kong; Chan Soo Shin
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-21

5.  Prediction of Gestational Diabetes Mellitus under Cascade and Ensemble Learning Algorithm.

Authors:  Jie Zhang; Fang Wang
Journal:  Comput Intell Neurosci       Date:  2022-07-14

Review 6.  Surgery for acromegaly: Indications and goals.

Authors:  David P Bray; Sai Mannam; Rima S Rindler; Joseph W Quillin; Nelson M Oyesiku
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-04       Impact factor: 6.055

Review 7.  Machine Learning Applications in Endocrinology and Metabolism Research: An Overview.

Authors:  Namki Hong; Heajeong Park; Yumie Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03

8.  Risk Assessment of Sarcopenia in Patients With Type 2 Diabetes Mellitus Using Data Mining Methods.

Authors:  Mengzhao Cui; Xiaokun Gang; Fang Gao; Gang Wang; Xianchao Xiao; Zhuo Li; Xiongfei Li; Guang Ning; Guixia Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-10       Impact factor: 5.555

9.  Development and Interpretation of Multiple Machine Learning Models for Predicting Postoperative Delayed Remission of Acromegaly Patients During Long-Term Follow-Up.

Authors:  Congxin Dai; Yanghua Fan; Yichao Li; Xinjie Bao; Yansheng Li; Mingliang Su; Yong Yao; Kan Deng; Bing Xing; Feng Feng; Ming Feng; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-16       Impact factor: 5.555

10.  First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence.

Authors:  V Cambria; G Beccuti; N Prencipe; F Penner; V Gasco; F Gatti; M Romanisio; M Caputo; E Ghigo; F Zenga; S Grottoli
Journal:  J Endocrinol Invest       Date:  2021-04-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.